Medbroker ApS: Financial statements 2022
CVR: 31892236
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
Medbroker ApS (CVR 31892236) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -56,504 and a net result of DKK -334,937 compared with DKK -343,350 the year before. Equity in the 2022 report amounted to DKK 925,367. The solvency ratio was 86.4%. The company had 1 employee in the financial year.
- Gross Profit
- DKK -56,504
- Profit/Loss
- DKK -334,937
- Equity
- DKK 925,367
- Total Assets
- DKK 1,070,557
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | -57 t. | -335 t. | 925 t. | 1 |
| 2021 | - | 130 t. | -343 t. | 1.3 mio. | 1 |
| 2020 | - | 646 t. | -182 t. | 1.6 mio. | 1 |
| 2019 | - | 1.1 mio. | 266 t. | 1.8 mio. | 2 |
| 2018 | - | 515 t. | 247 t. | 1.6 mio. | - |
Official annual report
Keep an eye on Medbroker ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
Medbroker ApS has published its annual report for 2021. Gross profit came to DKK 129,806, and the net result was DKK -343,350.
About Medbroker ApS
Medbroker ApS is a Danish company of the type Anpartsselskab based in Gadstrup, founded in 2009. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named ORIGO BIOTECH ApS. The management consists of Henrik Carlheim Dørge. The board consists of Henrik Carlheim Dørge (chair). The company is owned by MEDBROKER INVEST ApS. The company has 3 employees (2023). In 2025, the company reported a gross profit of DKK -6,226 and a net result of DKK -78,938 compared with DKK -406,760 the year before. Equity in the 2025 report amounted to DKK 34,714.